OBXObsidian Therapeutics Inc. Common Stock
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluat…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
 Obsidian Therapeutics (OBX) Stock Dropped, So What Is Behind The Attention Now? Obsidian Therapeutics stock reacts to new trial cohort and index inclusion Obsidian Therapeutics (OBX) is back in focus after enrolling the first patient in a registration enabling cohort for its Agni-01 trial of amsoki-cel in advanced melanoma, along with fresh index and capital structure moves. See our latest analysis for Obsidian Therapeutics. The latest trial milestone and index inclusion come after a sharp move in Obsidian Therapeutics stock, with a 1 month share price return of 18.68%... | ||
 Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls | TThe Fly | |
Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls | TThe Fly | |